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TransactivatorThe genome of bovine foamy virus (BFV) encodes a transcriptional transactivator, namely BTas, that
remarkably enhances gene expression by binding to the viral long-terminal repeat promoter (LTR) and
internal promoter (IP). In this report, we characterized the functional domains of BFV BTas. BTas contains
two major functional domains: the N-terminal DNA-binding domain (residues 1–133) and the C-terminal
activation domain (residues 198–249). The complete BTas responsive regions were mapped to the positions
−380/−140 of LTR and 9205/9276 of IP. Four BTas responsive elements were identiﬁed at the positions
−368/−346,−327/−307,−306/−285 and−186/−165 of the BFV LTR, and one element was identiﬁed at
the position 9243/9264 of the BFV IP. Unlike other foamy viruses, the ﬁve BTas responsive elements in BFV
shared obvious sequence homology. These data suggest that among the complex retroviruses, BFV appears to
have a unique transactivation mechanism.
Crown Copyright © 2010 Published by Elsevier Inc. All rights reserved.Introduction
Foamy viruses (FVs), also known as spumaretroviruses, are
members of a subfamily of Retroviridae. FVs represent a distinct
family of complex retroviruses and the former have been isolated
from several mammalian species, including humans (Achong et al.,
1971), nonhuman primates (Bieniasz et al., 1995; Broussard et al.,
1997; Herchenroder et al., 1994), and other species (Johnson et al.,
1983; Mochizuki et al., 1990; Tobaly-Tapiero et al., 2000). Although
FVs establish life-long persistent infection in the host, the pathogenic
potential of FVs has not been clearly established (Linial, 1999). Unlike
other retroviruses, FVs uniquely harbor an internal promoter (IP) in
addition to the conventional long-terminal repeat (LTR) (Linial,
1999). The FV genome encodes three structure genes, namely gag,
pol, and env, as well as the three regulatory genes, namely tas, bet, and
bel-2, that are located between the env gene and the 3′ LTR.
The prototype foamy virus (PFV) Bel1/Tas transactivator acts as a
key regulator of gene expression and directly binds to the Bel1
responsive element (BRE) in both the LTR and IP promoters,kai University, Tianjin 300071,
).
.
10 Published by Elsevier Inc. All riproducing a robust transcriptional transactivation (He et al., 1996).
Bel1 consists of at least two functional domains, an N-terminal/
central DNA-binding domain (DNA-BD) (residues 88–200) and a C-
terminal activation domain (residues 272–300) (He et al., 1993a). In
simian foamy virus (SFV), two potent activation domains (residues 1–
48 and 277–300) are identiﬁed in the Taf/Tas protein (Mergia et al.,
1993). The Tas responsive elements (TREs) of PFV, SFV-1, SFV-3, and
feline foamy virus (FFV) have been identiﬁed and are located in the U3
region of viral LTR. A recent study showed that the PFV LTR contains
three BREs located at the positions −360/−342, −327/−284, and
−116/−89 (Erlwein and Rethwilm, 1993), and the IP contains a
minimal Bel1-speciﬁc DNA target site located at −166/−140 within
the IP.BRE, upstream of the second cap site (Kang et al., 1998). A more
precise analysis of the Taf responsive region in SFV-1 and SFV-3
revealed that the 8249/8370 segment of SFV-1 IP and two segments
(−1196/−880 and −403/−125) in SFV-1 LTR respond to SFV-1 Taf
(Mergia et al., 1992; Zou and Luciw, 1996). Further, two segments
(−637/−496 and −496/−180) in SFV-3 LTR that confer Taf
responsiveness to a heterologous promoter have been mapped
(Renne et al., 1993). In the FFV LTR, two regions with the same
function have been mapped to −228/−195 and −66/−51 (Omoto
et al., 2004).
Bovine foamy virus (BFV) is the ﬁrst nonprimate FV that was
isolated in 1983 (Johnson et al., 1983). The genomic organization ofghts reserved.
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reading frames (ORFs) encoding the gag, pol, and env structural
genes and the btas and bet regulatory genes. The btas gene encodes a
249-amino acid (aa) regulatory protein termed BTas (Wang et al.,
2009). BTas is a DNA-binding protein that can transactivate both the
LTR and IP promoters similarly to PFV Bel1 (Tan et al., 2008; Wang
et al., 2009). However, the molecular basis of BTas-mediated
transactivation of its own LTR and IP, such as the binding and
activation domains of BTas and the precise localization of TRE in the
LTR and IP, is still unknown. In this study, we identiﬁed a DNA-BD at
the N-terminus and a potent transcriptional activation domain at the
C-terminus of BTas using deletion mutation analysis. Further, we
characterized the binding sequences of BTas on LTR and IP. Several
conserved bases in these sequences were found to be crucial for the
binding of BTas to its target sites.
Results
Identiﬁcation of the BTas binding regions on LTR and IP
Previous studies using deletion mutants and transient expression
suggested that LTR.TRE (−380/−140) was important for the
transactivation of BTas (Liu et al., 2000). Whether BTas can directly
bind to the LTR.TRE (−380/−140) and the precise sequence
requirement remains undeﬁned. To identify whether BTas can bind
to LTR.TRE (−380/−140) speciﬁcally in vitro, the electrophoretic
mobility shift assay (EMSA) was carried out. As shown in Fig. 1A,
puriﬁed BTas can bind to LTR.TRE (−380/−140) DNA probes, and the
complexes did not form when unlabeled LTR.TRE was added as
competitors. As a negative control, puriﬁed GST protein could not bind
to the LTR.TRE (−380/−140).
To determine the precise location of BTas the LTR.TRE, a set of LTR
segments were synthesized and labeled (Fig. 1B). As shown in Fig. 1A,
BTas could bind to two regions (−380/−277 and −310/−140) of
LTR.TRE, and the complexes were competed by unlabeled probes,Fig. 1. Identify the BTas responsive regions on LTR. (A) EMSA was performed with
puriﬁed GST or BTas. Digitonin-labeled LTR.TRE (−380/−140, −380/−277, −310/
−140, and−239/−170) probes were used. (B) Schematic representation of a series of
probes on LTR.TRE. All these probes were labeled by digitonin and then EMSA was
performed; the results of EMSA were presented with +/–.whereas BTas could not bind to the LTR.TRE (−239/−170) probe. In
addition, probes containing regions −310/−277, −310/−257,
−239/−140, −200/−140, −161/−140, and −186/−165 were
also tested, and the EMSA results were summarized in Fig. 1B. From
the above results, a 22-bp BTas responsive element was located in
−186/−165. We then performed sequence alignment to determine
whether other similar sequences are present in the LTR.TRE (−186/
−165). Indeed, conserved bases were found in three other elements
(−368/−346, −327/−307, −306/−285) on the LTR.TRE (Fig. 2A).
To test whether BTas can bind to these four elements separately, we
performed EMSA, and the results showed that BTas could speciﬁcally
bind to all four elements in vitro. As negative controls, puriﬁed GST
protein could not bind to these elements, and BTas could not bind to
the LTR.TRE (−161/−140) element (Fig. 2B).
The IP.TRE has been mapped to the position 9205/9275 (Zhang
et al., 2000). To determine the BTas responsive element on IP.TRE, we
performed sequence alignment of the IP.TRE and the four BTas
responsive elements on the LTR.TRE. A 22-bp element (9243/9264)
on IP.TRE exhibited a high homology (82%) to LTR.TRE (−306/−285)
(Fig. 3A). The speciﬁc binding of BTas to this 22-bp element was
subsequently conformed by EMSA (Fig. 3B).
These results suggested the presence of a conserved “TTA” triplet
in the C-terminal of the ﬁve BTas responsive elements. To further
investigate if this “TTA” triplet is required for BTas binding, we
mutated the “TTA” of LTR.TRE (−186/−165) to “CCC” (Fig. 4A). EMSA
indicated that BTas did not bind to the mutated −186/−165 (m)
probe but only bound to the wide type probe, which was used as a
positive control (Fig. 4B). These results suggested that the highly
conserved C-terminal “TTA” triplet is required for the binding of BTas
to the ﬁve BTas response elements.
Identiﬁcation of the DNA-binding sequence of BTas protein
EMSA revealed that BTas could directly bind to the LTR.TRE. To
further identify the DNA-binding domain of BTas involved in
transactivation, we constructed a series of glutathione S-transferase
(GST)-fused terminal deletion mutants of BTas and performed EMSA
using puriﬁed mutant proteins (Fig. 5A). The results suggested that
the BTas DNA-binding domain is located in the N terminal 1–133 aa,
as puriﬁed BTas mutant containing 27–249 aa could not bind to the
LTR.TRE, whereas the BTas mutants containing 1–133 aa and 1–217 aa
retained the ability to bind to LTR.TRE, as that observed with the wild-
type BTas protein (Fig. 5B). These results indicated that the N-Fig. 2. Identify the BTas responsive elements on LTR. (A) Sequence alignment the four
BTas responsive elements (−368/−346, −327/−307, −306/−285, and −186/165)
on LTR.TRE. (B) EMSA was performed with puriﬁed GST or BTas. Digitonin-labeled four
BTas binding regions and LTR (−161/−140) (a negative control) were used as the
probes.
Fig. 3. Identify the BTas responsive element on IP. (A) Sequence alignment LTR.TRE
(−306/−285) with IP.TRE (9243/9264). (B) EMSAwas performedwith puriﬁed GST or
BTas. Digitonin-labeled IP.TRE (9243/9264) and LTR (−161/−140) (a negative
control) were used as the probe.
Fig. 5. Identify theDNA-binding sequenceof BTasprotein. (A) Schematic representation of
BTas and deletion mutants. (B) EMSAwas performed with puriﬁed GST, BTas (1–217 aa),
BTas (1–133 aa), BTas (27–249 aa), or BTas. Digitonin-labeled LTR.TRE (−380/−140)was
used as the probes. (C) pCMV-AD-BTas (27–249 aa) or pCMV-AD-BTas (1–133 aa) was
transfected into 293T cells along with BFV LTR-luc reporter gene and pCMV-β-gal as
indicated. Forty-eight hours after transfection, luciferase activities were measured as
described in materials and methods. All transfections were performed in triplicate.
410 J. Tan et al. / Virology 405 (2010) 408–413terminal of BTas is indispensable whereas the 116 amino acids at the
C-terminal of BTas are not involved in the binding of BTas to the LTR.
In addition, we used a mammalian expression system to conﬁrm
the identiﬁed BTas DNA-binding domain in mammalian cells, using
BFV LTR-Luc reporter gene. The expression of the reporter gene can be
used to assess the DNA-binding capacity of a BTas domain fused to a
GAL4 activation domain (AD). A series of pCMV-AD-BTas deletion
mutants were constructed and cotransfected with BFV pLTR-luc and
pCMV-β-gal into 293T cells. Only marginal luciferase activity was
detected in cells contransfected with GAL4-AD-BTas (27–249 aa) and
BFV LTR-luc. In contrast, robust luciferase activity was detected when
293T cells were cotransfectedwith GAL4-AD-BTas (1–133 aa) and BFV
LTR-luc. Further, the induced luciferase activity signiﬁcantly increased
in a dose-dependent manner, whereas GAL4-AD did not show any
effect on the Gal4-Luc reporter gene (Fig. 5C). These results mapped
the DNA-binding domain of BTas to the N terminal 1–133 aa.
Identiﬁcation of the minimal activation domain of BTas
To identify the activation domain of BTas, we constructed a series
of pCMV-BD-BTas deletion mutants (Fig. 6A) and cotransfected them
with pFR-luc (GAL4-luc) and pCMV-β-gal. As shown in Fig. 6B, all N-
terminal truncated mutants, including BTas (90–249 aa), BTas (126–
249 aa), BTas (167–249 aa), and BTas (198–249 aa), retained full
activation ability. The minimal activation domain was mapped to theFig. 4. Identify the binding activity of BTas on LTR.TRE (−186/165) when mutated
conserved “TTA” to “CCC.” (A) Schematic representation of the mutation “TTA” of LTR.
TRE (−186/165) to “CCC.” (B) EMSA was performed with puriﬁed GST or BTas.
Digitonin-labeled LTR.TRE (−186/165) and LTR.TRE (−186/165m) were used as the
probes.198–249 aa of BTas, as C-terminal deletions including BTas (167–234
aa), BTas (198–234 aa), BTas (1–183 aa), and BTas (167–217 aa) all
led to attenuation or loss of the activation ability of BTas. These results
suggested that the 198 amino acids at the N-terminal of BTas were
dispensable, while the 52 amino acids at the C-terminal were essential
for the full activity of BTas. In addition, BTas contains an inhibitory
domain at residues 90–127, as the activation ability of BTas (90–249
aa) is similar to that of thewild-type BTas, whereas the activity of BTas
(126–249 aa), BTas (167–249 aa), and BTas (198–249 aa) is higher
than that of wild-type BTas.
In higher eukaryotes, there are three different sequence motifs in
the transcription activation domains: the acidic motif, glutamine-rich
motif, and proline-richmotif (Mitchell and Tjian, 1989). Among these,
only the acidic activation motif appears to function effectively in the
Saccharomyces cerevisiae. To examine whether the activation domain
of BTas also functions in yeast cells, we constructed a set of yeast
expression plasmids that expressed fusion constructs of GAL4 DNA-
BD and BTas mutants. We found that compared to yeast cells
transformed with a negative control GAL4-BD, those transformed
with GAL4-BD-BTas and GAL4-BD-BTas (198–249 aa) exhibited
robust β-galactosidase activity, whereas those transformed with
GAL4-BD-BTas (1–183 aa) only exhibited marginal β-galactosidase
activity (Fig. 6C). We therefore concluded that BTas contains a
Fig. 6. Identify the minimal activation domain of BTas. (A) Schematic representation of BTas and deletion mutants. (B) A series of pCMV-BD-BTas deletions were transfected into
293T cells along with pFR-luc reporter gene and pCMV-β-gal as indicated. Forty-eight hours after transfection, luciferase activities were measured as described in Materials and
methods. (C) β-Galactosidase activity in yeast cells transformed with the pGBKT7, pGBKT7-BTas (1–183 aa), pGBKT7-BTas (198–249 aa), or pGBKT7-BTas respectively. All
transfections were performed in triplicate.
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and that this sequence contains an acidic motif.
Discussion
Although the importance of BTas in the transactivation of BFV LTR
and IP and the replication of BFV is well established, the mechanisms
of BTas function and regulation remain unknown. Eukaryotic
transcription factors can be divided into discrete protein domains
that either direct the factor to the appropriate DNA target sequence or
permit the activation of transcription after binding has occurred.
Functional analyses of a series of BTas deletions revealed the presence
of at least two key functional domains that include an N-terminal
binding domain (1–133 aa) and a C-terminal activation domain (198–
249 aa).
The speciﬁc DNA-binding activities of several mammalian factors
have been localized to relatively small subregions consisting of 60–
100 aa. These studies have revealed that a DNA-BD is necessary but
not sufﬁcient for transcriptional activation. Three different types of
DNA-BDs of mammalian transcriptional factors have been described:
zinc ﬁnger motif in Sp1 (Kadonaga et al., 1987); homeodomain (HD)motif found in the octamer binding factors OCT-1, OCT-2, and the
pituitary-speciﬁc factor Pit-1 (GHF-1) (Clerc et al., 1988; Ingraham et
al., 1988; Ko et al., 1988; Muller et al., 1988; Sturm et al., 1988); and
leucine zipper motif in C/EBP, Jun, and Fos (Kouzarides and Ziff, 1988;
Landschulz et al., 1988a,b; Turner and Tjian, 1989). Deletion analysis
has revealed that the DNA-BD of BTas is localized to the N-terminal of
the protein. The DNA-BD region of BTas could form an α-helical
structure consistent with a DNA-binding structure, but it does not
have characteristic features of binding domains associated with zinc
ﬁngers, HDs, or leucine zippers. The primary sequences of several
other recently cloned mammalian transcription factors indicate that
there are other types of DNA-BDs in addition to the three described
previously. For example, AP-2 (Williams et al., 1988) and the serum-
response factor (SRF) (Norman et al., 1988) do not exhibit obvious
similarities to the above-mentioned binding domains or among
themselves.
Transcriptional activation domains can be divided into three key
classes on the basis of their amino acid sequences: the acidic motif
found in GAL4, GCN5, VP16, and p53 (He et al., 1993b; Van Hoy et al.,
1993); glutamine-rich motif of Sp1 (Courey and Tjian, 1988); and
proline-rich motif of CTF/NF-1 (Mermod et al., 1989). Similar to Bel1
412 J. Tan et al. / Virology 405 (2010) 408–413and Taf (Blair et al., 1994; Mergia et al., 1993), the activation domain
of BTas is a potent activator when fused to the GAL4 DNA-BD.
Therefore, BFV BTas, as least in this aspect, falls into the class of acidic
transcriptional transactivators. BTas do not show any strong amino
acid sequence homology to other acidic transcriptional transactiva-
tors, except for that one-fourth of the last 52 amino acids of BTas are
acidic. In addition, the activation domain of BTas contains a high
percentage of hydrophobic amino acids (34.6%). It was recently
reported that the mutations of speciﬁc hydrophobic residues within
the activation domain of herpes simplex virus (HSV) 1 VP16 and the
Epstein–Barr virus Rta severely impaired the transactivation ability
(Cress and Triezenberg, 1991; Hardwick et al., 1992; Ingles et al.,
1991; Regier et al., 1993), suggesting that either speciﬁc hydrophobic
interaction with protein partners or intramolecular folding is
important for transactivation. It remains to be determined whether
the activation domain of BTas functions via a novel mechanism
involving both hydrophobic residues and acidic residues.
Sequence comparisons between the BFV BTas protein and the
equivalent transactivators encoded by PFV, SFV-1, and SFV-3 reveal
little level of conservation (Flugel et al., 1987; Mergia et al., 1991;
Renne et al., 1992). A 15-aa conserved sequencemotif is located in the
activation domain of the three proteins Bel1, Taf1, and Taf3 (He et al.,
1993a), but this motif is not found in BTas. Different from Bel1, the
deletion of 15 amino acids at the C-terminal severely diminished the
activation ability of BTas. In contrast, the region from residues 90–127
appears to overcome the inhibitory effect. These results indicate that
BTas contains at least one positive and one negative regulatory
domain that modulate the distinct activation domain of BTas. The
similar negative domain was also found in Bel1 (Lee et al., 1994).
The expression of BFV genes, like that of PFV, is regulated by the
interplay of two viral promoters. In both the LTR and IP of BFV, the
target sequence for BTas has been mapped to the LTR U3 sequence
(−380/−140) (Liu et al., 2000) which is a typical inducible enhancer
and IP (9205/9276) (Zhang et al., 2000). Although this ﬁnding
strongly suggests that BTas acts via a DNA element, the precise
sequence requirements for BTas function and whether BTas interacts
directly or indirectly with its target sites have remained unclear.
Herein, we performed a detailed analysis of the BTas responsive
element in the LTR and IP of BFV. EMSA experiments revealed that
BTas alone can directly bind to the TRE. In addition, sequence
alignment and EMSA revealed four elements (−368/−346, −327/
−307, −306/−285, and −186/−165) in the BFV LTR and one
element (9243/9264) in the BFV IP. Unlike PFV, SFV-1, and SFV-3, the
BFV TREs exhibit sequence homologies, and mutation of the
conserved bases “TTA” in one of the TREs leads to the loss of binding
ability of BTas. However, to our knowledge, the sequence does not
show obvious homologies to known eukaryotic enhancer sequence
motifs.
In this paper, we showed that the biological function domains of
BTas involve an important DNA-BD and an active transcription
activation domain. Further, we identiﬁed the ﬁve TREs of the BTas
that binds to the LTR and IP. BTasmight directly bind to the TREs in the
LTR and IP through the N-terminal binding domain, whereas the C-
terminal activation domain may recruit cellular cofactors required for
BTas-mediated activation of transcription.
Materials and methods
Cloning of the plasmids
BFV pCMV-BTas and pLTR-luc were constructed as described
previously (Liu et al., 1999). The pGEX-6p-1-BTas (1–133 aa), pGEX-
6p-1-BTas (1–217 aa), pGEX-6p-1-BTas (27–249 aa), and pGEX-6p-1-
BTas were constructed by inserting individual PCR fragment into the
pGEX-6p-1 (Amersham Pharmacia). The pCMV-AD-BTas (27–249 aa),
pCMV-AD-BTas (1–133 aa), pCMV-BD-BTas (90–249 aa), pCMV-BD-BTas (126–249 aa), pCMV-BD-BTas (167–249 aa), pCMV-BD-BTas
(198–249 aa), pCMV-BD-BTas (167–217 aa), pCMV-BD-BTas (167–
234 aa), pCMV-BD-BTas (198–234 aa), pCMV-BD-BTas (1–184 aa),
and pCMV-BD-BTas were constructed by inserting individual PCR
fragment into the pCMV-BD or pCMV-AD vector (Invitrogen). The
pGBKT7-BTas (1–183 aa), pGBKT7-BTas (198–249 aa) and pGBKT7-
BTas were constructed by inserting individual PCR fragment into the
pGBKT7 vector (Clontech). All the new constructs were conﬁrmed by
sequencing.
Cell culture, transfection, and luciferase reporter assays
293T cells were grown in Dulbecco's modiﬁed Eagle medium
(DMEM) (GIBCO, Grand Island, NY) supplemented with 10% fetal
bovine serum (FBS) and antibiotics. 293T cells were seeded at 1×105
cells per well in 12-well plates. The following day, cells were
transfected with pFR-luc and a series of pCMV-BD-BTas deletions,
with pCMV β-gal as the control of transfection efﬁciency using
polyethylenimines (PEI) according to the manufacturer's protocol
(Durocher et al., 2002). Total amount of DNA were equilibrated by
adding parent plasmids. At 48 h after transfection, the cells were
harvested and luciferase assays (Promega) were performed. The
luciferase activities were normalized by β-galactosidase activities. All
transfections were performed in triplicate.
Yeast transactivation studies
The pGBKT7, pGBKT7-BTas (1–183 aa), pGBKT7-BTas (198–249
aa), or pGBKT7-BTas plasmids were transformed into the yeast strain
AH109. After three days of growth selection on SD/–Trp plates at
30 °C, at least three colonies isolated from plates were grown in liquid
culture and assayed for β-galactosidase (β-Gal) activity by standard
protocols.
Electrophoretic mobility shift assay (EMSA)
GST fusion proteins were expressed in Escherichia coli strain BL21
and subsequently puriﬁed by glutathione sepharose beads (Amer-
sham Biosciences) with PreScission Protease according to the
manufacturer's instruction. Protein concentrations were determined
by Bradford assay. The binding reactionwas carried out with 500 ng of
puriﬁed protein.
The BFV LTR probes (−380/−140, −380/−277, −310/−140,
−239/−140, −200/−140, and −239/−170) used for EMSA were
generated by PCR, other probes (−368/−346, −327/−307, −310/
−277, −310/−257, −306/−285, −186/−165 , −161/−140, and
9243/9264) were synthesized and annealed. All probes were labeled
by digitonin using the DIG Gel Shift Kit (Roche). For competition
experiments, unlabeled competitor oligodeoxynucleotides were
added in 20-fold molar excess at the preincubation period.
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